Boston Scientific Corp (NYSE:BSX)
$ 90.75 0.54 (0.6%) Market Cap: 133.75 Bil Enterprise Value: 142.51 Bil PE Ratio: 75.00 PB Ratio: 6.46 GF Score: 86/100

Q2 2023 Boston Scientific Corp Earnings Call Transcript

Jul 27, 2023 / 11:30AM GMT
Release Date Price: $52.64 (+0.46%)
Operator

Good day, and welcome to the Boston Scientific Q2 2023 Earnings Conference Call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Lauren Tengler, Vice President and Investor Relations. Please go ahead.

Lauren Tengler
Boston Scientific Corporation - Director of IR

Thank you, Kyle. Welcome, everyone, and thanks for joining us today. With me on today's call are Mike Mahoney, Chairman and Chief Executive Officer; and Dan Brennan, Executive Vice President and Chief Financial Officer.

We issued a press release earlier this morning announcing our Q2 '23 results, which included reconciliations of the non-GAAP measures used in the release. We have posted a copy of that release as well as reconciliations on the non-GAAP measures used in today's call to the Investor Relations section of our website under the heading Financials and Filings. The duration of this morning's call will be approximately 1 hour.

Mike and Dan will provide comments on Q2 performance as well as the outlook for our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot